JM
At a glance
Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
7
9 agencies contacted
Activity
filings by quarter
Works on
Health Issues 7Budget/Appropriations 4Civil Rights/Civil Liberties 4Consumer Issues/Safety/Products 4Copyright/Patent/Trademark 4Defense 4Energy/Nuclear 4Environment/Superfund 4Family issues/Abortion/Adoption 4Food Industry (safety, labeling, etc.) 4Foreign Relations 4Veterans 4Agriculture 4Labor Issues/Antitrust/Workplace 4Manufacturing 4Medicare/Medicaid 4Pharmacy 4Taxation/Internal Revenue Code 4Tobacco 4Trade (domestic/foreign) 4Government Issues 2
Background
Government experience
Leg. Dir
Rep. Nydia M. Velazquez, Nov 2019-March 2022;Sr Leg Asst, Rep. Nydia M. Velazquez, May 2017-Nov 2019;Leg Asst, October 2016-April 2017; Staff Asst, May 2014-Sept 2016 Comm on Small Business, Leg Dir, Oct 1, 2021-March 15, 2022
Disclosed on LD-2 filings
Career
HU
Specific issues
Issues related to consumer health care
General health inclusivity issues
General international trade policy related to tariffs, import, export concerns; General monitoring of legislative and administrative action related to foreign regulation of chemicals, ingredients, and health care products; General monitoring of legislative and administrative action related to implementation of the United States-Mexico-Canada Agreement (USMCA); and General review and monitoring of global supply chain concerns
General monitoring of legislative and administrative action related to Medicare and Medicaid policy, including changes in coverage/eligibility. General monitoring of Medicare coverage of dental services; General review of legislation, rulemaking impacting dual eligible enrollees
General monitoring of legislative and administrative action related to health care policy; including the OTC Monograph Drug User Fee Program (OMUFA). General monitoring of legislative and administrative action related to womens health issues; General monitoring of legislative and administrative action related to over-the-counter consumer healthcare products; General monitoring of legislative and administrative action related to dietary supplements, multivitamin, and hunger issues; General monitoring of legislative and administrative action related to FDA monograph reform and user fees; General monitoring of legislative and administrative action related to the switch of prescription medications to over-the-counter medications; Review of coverage for medically necessary services in Medicare and Medicare Advantage General review and monitoring of processes impacting over-the-counter switches, including Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU) rulemaking process; Legislative and administrative action related to pseudoephedrine regulation; General monitoring of issues related to the reauthorization of "Pandemic and All-Hazards Preparedness Act" PAHPA; Review of legislation impacting the Dietary Supplement Health and Education Act of 1994, in particular, provisions related to Mandatory Product Listing (MPL); H.R. 831 Medicare Medically Necessary Dental Care Act of 2023; H.R. 994/S. 403 Oral Health Literacy Awareness Act; S.842 - Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2023; H.R. 6284 Improving Measurements for Loneliness and Isolation Act; H.R. 4150/S.1954 Improving Whole Health for Veterans with Chronic Conditions Act; H.R. 4146 /S.2012 Medicare Dental Benefit Act of 2023 S.3393 SUPPORT for Patients and Communities Reauthorization Act, specifically provisions related to non-opioid alternatives to acute and chronic pain management; General review of legislation and amendments focusing on non-addictive, non-opioid pain management medications, with a focus on over-the-counter (OTC) options; and Monitoring of regulatory proposals impacting inclusion of routine non-pediatric dental services as Essential Health Benefits (EHBs)
General monitoring of legislative and administrative action related to intellectual property protection.